
    
      Participants with hypertension who were treated with antihypertensive agents were randomly
      assigned to an active (KRG 2 g/day) or a placebo treatment group in a double-blind cross over
      manner.

      Participants were not allowed to change their antihypertensive medications except safety
      issue. Brachial systolic BP (SBP), diastolic BP (DBP), Central SBP and DBP will measured at
      baseline,at 2 and 4 months.

      Efficacy and safety data will be monitored by Daegu Catholic University Medical Center
      Institutional Review Board and reported to the Korean Ginseng Society.
    
  